#354: ICMRA Post-Pandemic: Regulators Looking into the Future
Wednesday, June 19, 2024 1:15 PM to 2:15 PM · 1 hr. (US/Pacific)
Room 6A
09: Regulatory
Information
ICMRA regulators will share their views on the opportunities and challenges brought by some of the main innovative concepts and technologies they are facing, including artificial intelligence, evolving clinical trials, and real-world evidence in the authorization of advanced therapy medical products (ATMPs).
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Real-World Data (RWD)- Real-World Evidence (RWE)Decentralized Clinical Trials (DCTs)
Speakers

Emer Cooke
Chair, ICMRA; Executive DirectorEuropean Medicines AgencyABT
Antonio Barra Torres
President DirectorANVISA
Lorraine Nolan
Chief ExecutiveHealth Products Regulatory Authority
Robert Califf
Instructor, MedicineDuke University School of Medicine
Anthony Lawler
Deputy Secretary, Health Products Regulation GroupTherapeutic Goods Administration
